NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Pharma Mar S.A (MC: PHM)
PHM Technical Analysis
5
As on 21st Nov 2024 PHM STOCK Price closed @ 73.10 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 33.97 & Strong Buy for SHORT-TERM with Stoploss of 32.96 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHMSTOCK Price
Open | 74.35 | Change | Price | % |
High | 74.80 | 1 Day | -1.45 | -1.95 |
Low | 72.60 | 1 Week | -7.65 | -9.47 |
Close | 73.10 | 1 Month | 25.52 | 53.64 |
Volume | 37204 | 1 Year | 40.68 | 125.48 |
52 Week High 80.75 | 52 Week Low 26.24 |
MC Spain Most Active Stocks
UBS | 0.00 | % |
SAN | 4.53 | 0.44% |
CABK | 5.46 | 0.92% |
DIA | 0.01 | 0.00% |
IAG | 2.96 | 1.72% |
TEF | 4.26 | -1.62% |
SAB | 1.84 | 0.55% |
IBE | 13.32 | -0.22% |
BBVA | 9.25 | 0.22% |
UNI | 1.24 | 0.81% |
MC Spain Top Gainers Stocks
MC Spain Top Losers Stocks
PHM Daily Charts |
PHM Intraday Charts |
Whats New @ Bazaartrend |
PHM Free Analysis |
|
PHM Important Levels Intraday
RESISTANCE | 77.34 |
RESISTANCE | 75.98 |
RESISTANCE | 75.14 |
RESISTANCE | 74.30 |
SUPPORT | 71.90 |
SUPPORT | 71.06 |
SUPPORT | 70.22 |
SUPPORT | 68.86 |
PHM Forecast November 2024
4th UP Forecast | 83.2 |
3rd UP Forecast | 79.96 |
2nd UP Forecast | 77.96 |
1st UP Forecast | 75.96 |
1st DOWN Forecast | 70.24 |
2nd DOWN Forecast | 68.24 |
3rd DOWN Forecast | 66.24 |
4th DOWN Forecast | 63 |
PHM Weekly Forecast
4th UP Forecast | 77.15 |
3rd UP Forecast | 75.85 |
2nd UP Forecast | 75.05 |
1st UP Forecast | 74.24 |
1st DOWN Forecast | 71.96 |
2nd DOWN Forecast | 71.15 |
3rd DOWN Forecast | 70.35 |
4th DOWN Forecast | 69.05 |
PHM Forecast2024
4th UP Forecast | 183.98 |
3rd UP Forecast | 148.42 |
2nd UP Forecast | 126.44 |
1st UP Forecast | 104.46 |
1st DOWN Forecast | 41.74 |
2nd DOWN Forecast | 19.76 |
3rd DOWN Forecast | -2.22 |
4th DOWN Forecast | -37.78 |
Pharma Mar S.A ( MC Spain Symbol : PHM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PHM Other Details
Segment | EQ | |
Market Capital | 1266828160.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
PHM Address
PHM Latest News
PHM Business Profile
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops clinical-stage programs, including PM184 and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain. Address: Avenida de los Reyes, 1, Madrid, Spain, 28770
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service